GILDER GAGNON HOWE & CO LLC
SC 13G, 1999-09-10
Previous: GILDER GAGNON HOWE & CO LLC, SC 13G, 1999-09-10
Next: MODERN MEDICAL MODALITIES CORP, SB-2, 1999-09-10





                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                               -------------------

                    Under the Securities Exchange Act of 1934

                                  SCHEDULE 13G

             INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2
                    UNDER THE SECURITIES EXCHANGE ACT OF 1934

                            Negen Results Corporation
                            -------------------------
                                (Name of Issuer)

                                  Common Stock
                         ------------------------------
                         (Title of Class of Securities)


                                    651359101
                               -------------------
                                 (CUSIP Number)


                                 August 31, 1999
             -------------------------------------------------------
             (Date of Event Which Requires Filing of this Statement)



Check  the  appropriate  box to  designate  the rule  pursuant  to  which  this
Schedule is filed: |X|
        Rule 13d-1(b) |_|
        Rule 13d-1(c) |_|
        Rule 13d-1(d)

                                 ---------------



                                Page 1 of 6 Pages
<PAGE>



                                         SCHEDULE 13G

CUSIP No.  651359101                                           Page 2 of 6 Pages
- --------------------------------------------------------------------------------
1)      NAME OF REPORTING PERSON
        S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

        Gilder Gagnon Howe & Co. LLC
        13-3174112
- --------------------------------------------------------------------------------
2)      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP               (a) |_|

                                                                       (b) |_|
- --------------------------------------------------------------------------------
3)      SEC USE ONLY

- --------------------------------------------------------------------------------
4)      CITIZENSHIP OR PLACE OF ORGANIZATION

        New York
- --------------------------------------------------------------------------------
                         5)    SOLE VOTING POWER
                               None
        NUMBER           -------------------------------------------------------
        OF               6)    SHARED VOTING POWER
        SHARES                 None
        BENEFICIALLY     -------------------------------------------------------
        OWNED BY         7)    SOLE DISPOSITIVE POWER
        EACH                   None
        REPORTING        -------------------------------------------------------
        PERSON           8)    SHARED DISPOSITIVE POWER
        WITH
                               480,625

9)      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

        480,625
- --------------------------------------------------------------------------------
10)     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
        SHARES                                                              |_|
- --------------------------------------------------------------------------------
11)     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

        5.1%
- --------------------------------------------------------------------------------
12)     TYPE OF REPORTING PERSON

        BD
- --------------------------------------------------------------------------------

                                Page 2 of 6 Pages
<PAGE>

                                  Schedule 13G

Item 1(a). Name of Issuer:

Newgen Results Corporation

Item 1(b). Address of Issuer's Principal Executive Offices:

12680 High Bluff Drive
Suite 300
San Diego, CA  92130

Item 2(a). Name of Person Filing:

Gilder Gagnon Howe & Co. LLC

Item 2(b). Address of Principal Business Office or, if None, Residence:

1775 Broadway, 26th Floor
New York, NY  10019

Item 2(c). Citizenship:

New York

Item 2(d). Title of Class of Securities:

Common Stock

Item 2(e). CUSIP Number:

651359101

Item 3.    If this  statement  is filed  pursuant to  ss.ss.240.13d-1(b),  or
           240.13d-2(b) or (c), check whether the person filing is a:

           (a) |X|  Broker or Dealer Registered Under Section 15 of the Act
                    (15 U.S.C. 78o)

           (b) |_|  Bank as defined in section 3(a)(6) of the Act
                    (15 U.S.C. 78c)

           (c) |_|  Insurance  Company as defined in section  3(a)(19) of the
                    Act (15 U.S.C. 78c)

           (d) |_|  Investment  Company  registered  under  section  8 of the
                    Investment Company Act of 1940 (15 U.S.C. 80a-8)

           (e) |_|  Investment Adviser in accordance with ss.240.13d-1(b)
                    (1)(ii)(E)


                                     Page 3 of 6 Pages

<PAGE>

           (f)  |_| Employee benefit plan or endowment fund in accordance with
                    ss.240.13d-1(b)(1)(ii)(F)

           (g)  |_| Parent  Holding  Company or control  person in  accordance
                     with ss.240.13d-1(b)(ii)(G)

           (h)  |_| Savings  Association  as defined in ss.3(b) of the Federal
                    Deposit Insurance Act (12 U.S.C. 1813)

           (i)  |_| Church plan that is  excluded  from the  definition  of an
                    investment company under ss.3(c)(15) of the Investment
                    Company Act of 1940 (15 U.S.C. 80a-3)

           (j)  |_| Group, in accordance with ss.240.13d-1(b)(ii)(J)

Item 4.    Ownership.

           (a)  Amount beneficially owned:  480,625

           (b)  Percent of class:  5.1%

           (c) Number of shares as to which such person has:

                  (i)   Sole power to vote or to direct the vote: None

                  (ii)  Shared power to vote or to direct the vote: None

                  (iii) Sole power to dispose or to direct the  disposition  of:
                        None

                  (iv)  Shared power to dispose or to direct the disposition of:
                        480,625

The shares reported include 467,850 shares held in customer  accounts over which
members and/or employees of the Reporting Person have discretionary authority to
dispose of or direct the  disposition  of the shares,  and 12,775 shares held in
accounts owned by the partners of the Reporting Person and their families.  Item

5. Ownership of Five Percent or Less of a Class.

Not applicable


                                Page 4 of 6 Pages

<PAGE>

Item 6.    Ownership of More than Five Percent on Behalf of Another Person.

           The  owners of the  accounts  in which the  shares  reported  on this
Schedule  are held have the right to receive or the power to direct the  receipt
of dividends from, or the proceeds from the sale of, such securities.

Item 7.    Identification and Classification of the Subsidiary Which Acquired
           the Security Being Reported on by the Parent Holding Company.

Not applicable

Item 8.    Identification and Classification of Members of the Group.

Not applicable

Item 9.    Notice of Dissolution of Group.

Not applicable

Item 10.   Certification.

           By signing  below I certify  that,  to the best of my  knowledge  and
belief, the securities referred to above were acquired in the ordinary course of
business  and were not acquired for the purpose of and do not have the effect of
changing or  influencing  the control of the issuer of such  securities and were
not acquired in connection  with or as a participant in any  transaction  having
such purposes or effect.


                                Page 5 of 6 Pages

<PAGE>

                                    SIGNATURE


           After reasonable  inquiry and to the best knowledge and belief of the
undersigned,  the  undersigned  certifies that the information set forth in this
Statement is true, complete and correct.


                                    SIGNATURE

           After reasonable  inquiry and to the best knowledge and belief of the
undersigned,  the  undersigned  certifies that the information set forth in this
Statement is true, complete and correct.


                                    September 10, 1999
                                    ----------------------------
                                        Date

                                    /s/Walter Weadock
                                    ----------------------------
                                        Signature

                                    Walter Weadock, Member
                                    -------------------------------
                                        Name/Title

                                Page 6 of 6 Pages


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission